Prokidney (PROK) EBT (2021 - 2026)

Prokidney (PROK) has 6 years of EBT data on file, last reported at -$42.6 million in Q1 2026.

• EBT for Q1 2026 came in at -$42.6 million, down 14.08% year-over-year; the trailing twelve-month figure through Mar 2026 was -$156.5 million (up 5.78% YoY), and the FY2025 annual result was -$151.2 million, up 7.77% from the prior year.
• EBT was little changed at -$42.6 million in Q1 2026 per PROK's latest filing, from -$42.4 million in the prior quarter.
• Over five years, EBT peaked at -$18.9 million in Q4 2023 and troughed at -$66.5 million in Q1 2022.
• A 5-year average of -$37.3 million and a median of -$36.1 million in 2025 frame the typical range for EBT.
• The sharpest annual moves came in 2022 and 2023: EBT slumped 1282725.16% in 2022, then jumped 46.47% in 2023.
• A 5-year view of EBT shows it stood at -$25.8 million in 2022, then increased by 26.72% to -$18.9 million in 2023, then plunged by 147.09% to -$46.8 million in 2024, then climbed by 9.29% to -$42.4 million in 2025, then dropped by 0.43% to -$42.6 million in 2026.
• Business Quant data shows PROK's EBT at -$42.6 million in Q1 2026, -$42.4 million in Q4 2025, and -$35.3 million in Q3 2025.